Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Ovarian Epithelial

Explore clinical trials studying Carcinoma, Ovarian Epithelial. Study availability and eligibility vary by location and protocol.

539 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Ovarian Epithelial trial results

Active, not recruiting

First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

NCT06121401

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +16 more
Locations
  • Azienda Socio Sanitaria Territoriale (ASST) Lariana San Fermo della Battaglia, Como, Italy
  • Spedali Civili Brescia, Italy
  • Policlinico Careggi Florence, Italy
  • Ospedale Manzoni Lecco, Italy
View all 14 locations
View Trial Details
Active, not recruiting

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

NCT03872947

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +58 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • AOA-HOPE Tucson, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • HOAG Memorial Hospital Presbyterian Newport, California, United States
View all 14 locations
View Trial Details
Active, not recruiting

Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

NCT03393884

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Mitchell Cancer Institute (University of South Alabama) Mobile, Alabama, United States
  • Gynecologic Oncology Associates (Hoag Hospital) Newport Beach, California, United States
  • Innovative Clinical Research Whittier, California, United States
View all 21 locations
View Trial Details
Active, not recruiting

A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.

NCT05335993

Conditions
Adenocarcinoma of Ovary, Adnexal Diseases, Carcinoma, +25 more
Locations
  • Duke Cancer Center Durham, North Carolina, United States
  • Stephenson Cancer Center- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
  • University of Virginia Health System Charlottesville, Virginia, United States
View Trial Details
Active, not recruiting

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

NCT04498117

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • John Muir Health Clinical Research Center Concord, California, United States
  • Kaiser Permanente Southern California Irvine, California, United States
View all 148 locations
View Trial Details
Active, not recruiting

Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

NCT05116189

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +20 more
Locations
  • HonorHealth ( Site 0041) Phoenix, Arizona, United States
  • Marin Cancer Care ( Site 0055) Greenbrae, California, United States
  • Pacific Cancer Care ( Site 0028) Monterey, California, United States
  • Eisenhower Medical Center ( Site 0067) Rancho Mirage, California, United States
View all 187 locations
View Trial Details

Related conditions